
|Articles|November 23, 2022
Incyte Biosciences United Kingdom and Ireland Appoints Peter Williams As General Manager
Advertisement
Incyte announces the appointment of Peter Williams as General Manager for Incyte Biosciences United Kingdom and Ireland. In his role, Peter will be responsible for the development of medical, regulatory and commercial strategy for Incyte’s portfolio of products in the UK and Ireland.
“On behalf of our leadership team, I would like to welcome Peter to Incyte. His extensive commercial experience will greatly enhance the teams in the UK & Ireland and support our continued growth,” said Jonathan Dickinson, Executive Vice President and General Manager for Incyte Europe.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal
2
Marty Makary Out as FDA Commissioner: Report
3
The Insight Gap: Biopharma’s Hidden Risk in the Race Against the Patent Cliff
4
From Consulting to Venture Capital: A Q&A with Gibb Witham, President of Hack The Box
5




